Sharon Elad

Prof. Sharon Elad


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2020 in Cancer
Verified
Journal Article
Open access
PDF file
SESharon Elad
Sharon Elad
KCKaris Kin Fong Cheng
Karis Kin Fong Cheng
RLRajesh V. Lalla
Rajesh V. Lalla
NYNoam Yarom
Noam Yarom
CHCatherine Hong
Catherine Hong
F(for the Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO)
for the Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO)
Background: Mucositis is a significant toxicity of cancer therapy with numerous systemic sequelae. The goal of this systematic review was to update the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) Clinical Practice Guidelines for the management of mucositis.Methods: The literature was reviewed systematically to identify interventions for mucositis. Studies were rated according to the presence of major and minor flaws according to previously published criteria. The body of evidence for each intervention and in each treatment setting was assigned a level of evidence based on previously published criteria. Guidelines were developed based on the level of evidence, with 3 possible guideline determinations: recommendation, suggestion, or no guideline possible.Results: The guideline covers evidence from 1197 publications related to oral or gastrointestinal mucositis. Thirteen new guidelines were developed for or against the use of various interventions in specific treatment settings, and 11 previous guidelines were confirmed after aa review of new evidence. Thirteen previously established guidelines were carried over because there was no new evidence for these interventions.Conclusions: The updated MASCC/ISOO Clinical Practice Guidelines for mucositis provide professional health caregivers with a clinical setting‐specific, evidence‐based tool to help with the management of mucositis in patients who have cancer.

29 October 2021 in CA: A Cancer Journal for Clinicians
Verified
Journal Article
Open access
PDF file
SESharon Elad
Sharon Elad
Noam YaromNoam Yarom
Noam Yarom
Yehuda ZadikYehuda Zadik
Yehuda Zadik
MKMichal Kuten‐Shorrer
Michal Kuten‐Shorrer
SSStephen T. Sonis
Stephen T. Sonis
Oral mucositis (OM) is a common, highly symptomatic complication of cancer therapy that affects patients' function, quality of life, and ability to tolerate treatment. In certain patients with cancer, OM is associated with increased mortality. Research on the management of OM is ongoing. Oral mucosal toxicities are also reported in targeted and immune checkpoint inhibitor therapies. The objective of this article is to present current knowledge about the epidemiology, pathogenesis, assessment, risk prediction, and current and developing intervention strategies for OM and other ulcerative mucosal toxicities caused by both conventional and evolving forms of cancer therapy.


5 September 2014 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
SESharon Elad
Sharon Elad
JRJudith E. Raber-Durlacher
Judith E. Raber-Durlacher
MBMichael T. Brennan
Michael T. Brennan
DSDeborah P. Saunders
Deborah P. Saunders
AMArno P. Mank
Arno P. Mank
SJSiri Beier Jensen
Siri Beier Jensen
Purpose Hematology–oncology patients undergoing chemotherapy and hematopoietic stem cell transplantation (HSCT) recipients are at risk for oral complications which may cause significant morbidity and a potential risk of mortality. This emphasizes the importance of basic oral care prior to, during and following chemotherapy/HSCT. While scientific evidence is available to support some of the clinical practices used to manage the oral complications, expert opinion is needed to shape the current optimal protocols. Methods This position paper was developed by members of the Oral Care Study Group, Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT) in attempt to provide guidance to the health care providers managing these patient populations. Results The protocol on basic oral care outlined in this position paper is presented based on the following principles: prevention of infections, pain control, maintaining oral function, the interplay with managing oral complications of cancer treatment and improving quality of life. Conclusion Using these fundamental elements, we developed a protocol to assist the health care provider and present a practical approach for basic oral care. Research is warranted to provide robust scientific evidence and to enhance this clinical protocol.


22 September 2012 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
F(For the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO)
For the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO)
CMCesar Migliorati
Cesar Migliorati
IHIan Hewson
Ian Hewson
RLRajesh V. Lalla
Rajesh V. Lalla
HAHeliton Spindola Antunes
Heliton Spindola Antunes
SESharon Elad
Sharon Elad
The aim of this study was to review the available literature and define clinical practice guidelines for the use of laser and other light therapies for the prevention and treatment of oral mucositis.